Dr. Copeland et al., NEUROPSYCHOLOGIC EFFECTS OF CHEMOTHERAPY ON CHILDREN WITH CANCER - A LONGITUDINAL-STUDY, Journal of clinical oncology, 14(10), 1996, pp. 2826-2835
Purpose: A prospective study was conducted to assess the effects of ch
emotherapy for cancer on children's long-term neuropsychologic status.
Patients and Methods: Ninety-nine children who received no cranial th
erapy (CRT) completed four annual neuropsychologic assessments. Fifty-
one patients received intrathecal (IT) chemotherapy (ITC); 48 received
no CNS treatment. These two groups were compared using repeated-measu
res analysis of variance on IQ, memory, language, freedom from distrac
tibility, academic achievement, executive functions, and fine-motor, p
erceptual-motor, and tactile-spatial skills. In addition, 51 of the sa
mple of 99 patients had been examined 5 to 11 years after diagnosis. T
heir data were analyzed to evaluate the longer-term effects of chemoth
erapy. The predictability of demographic and medical variables on neur
opsychologic: outcome at 8-year and long-term follow-up study were ass
essed using multiple regression techniques. Results: Overall, the effe
cts of chemotherapy in the absence of CRT appear to be slight. Patient
s who received ITC and intravenous (IV) methotrexate declined slightly
on perceptual-motor skills, but were still well within the normal ran
ge. Both groups, regardless of treatment, declined on academic achieve
ment tests, although not to a statistically significant degree. Age ef
fects were found on performance IQ (PIQ) and perceptual-motor skills.
Socioeconomic status (SES) correlated with a large number of variables
. Sex effects were not significant. Conclusion: The present results ar
e largely consistent with previous findings for nonirradiated groups.
Treatment effects from ITC are slightly more apparent 5 to 11 years af
ter diagnosis than at 9-year follow-up evaluation but this does not co
nstitute a clinically meaningful difference. More noticeable ore acade
mic declines among all groups, regardless of treatment. (C) 1996 by Am
erican Society of Clinical Oncology.